UNIVERSITY OF SURREY: The Imperial College study team have recorded baseline characterisation of approximately 30,000 Indian Asian men and women aged 35-74 years and free from clinically manifest cardio

Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.

Organisation: UNIVERSITY OF SURREY
Source reference: DARS-NIC-203503-X7K8K-v0.4
Jurisdiction: England
Licence: Open Government Licence v3.0, subject to NHS England terms and exclusions

Register reference: DARS-NIC-203503-X7K8K-v0.4
Agreement period: not published to no end date published
For commercial purposes (as marked in the register): Not stated
Release files listed by NHS England: 41

Data approved

Hospital Episode Statistics Admitted Patient Care
Hospital Episode Statistics Accident and Emergency
Hospital Episode Statistics Outpatients
Office for National Statistics Mortality Data

Objective, as published

The Imperial College study team have recorded baseline characterisation of approximately 30,000 Indian Asian men and women aged 35-74 years and free from clinically manifest cardiovascular disease (CVD), in the London Life Sciences Prospective Population (LOLIPOP) study. LOLIPOP aims to precisely calculate the increased vascular risk for British Asians. Health economic analysis of the introduction of the CVD risk prediction calculator for use in Indian Asians will be performed as well as a qualitative study to evaluate the utility and acceptability to general practitioners and individuals of implementing the CVD risk prediction model in general practice. In parallel University of Surrey will develop models and conduct an economic evaluation to examine the cost-effectiveness of using the new risk estimator to detect the number of Asian men at risk. This includes the costs of identifying the cohort using the new risk estimator and putting them in a preventative scheme, and the benefit, both in terms of improved health outcomes and associated reduced health care costs

Expected benefits, as published

The high CVD morbidity and mortality amongst the Asian population compared to Europeans represents a significant health inequality which needs to be explored, explained and addressed. Currently the precise risk is not known, so the costs effectiveness of a possible greater intensity of cholesterol, blood pressure and other interventions can’t be defined. Inclusion of enhanced treatment in national and international guidelines generally requires demonstration of cost effectiveness. By precisely calculating risk the University of Surrey will enable cost-effectiveness of any enhanced intervention to be determined. The current recommended method for risk prediction is NOT adequate for this group and uncertainty of risk leads generally to standard guidelines being applied and the consequent un…

Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/24614/Release-Register-March---May-2017/xls/Release_Register__March_-_May_20171.xlsx. Captured 2026-10-30.

Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.